TrialJournal of inherited metabolic disease2018

Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis.

Allan M Lund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.